Genialis is a precision oncology company helping the most promising molecules become life-saving medicines. They develop and validate clinically actionable biomarkers informed by diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes.

Genialis is a precision oncology company helping the most promising molecules become life-saving medicines. They develop and validate clinically actionable biomarkers informed by diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes.